JS
SGYP

Jeffrey Smith’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Jeffrey Smith’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-525,000
Closed -$4.36M – 43
2015
Q2 		$4.36M Buy
+525,000
New +$2.54M 0.1% 33

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jeffrey Smith's SGYP Position: Q3 2015 in Review

Jeffrey Smith sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015, closing a stake of 525,000 shares — an estimated $4.36M sold.

Jeffrey Smith first reported a position in SGYP in Q2 2015 and held it in 1 quarter. The position peaked at $4.36M in Q2 2015. 129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

  • Jeffrey Smith reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2015 after selling out during the quarter.
  • Jeffrey Smith sold 525,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2015, an estimated $4.36M.
  • Jeffrey Smith first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 1 quarter.
  • Jeffrey Smith's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.36M in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Starboard Value's 13F filing for Q3 2015, filed 13 Nov 2015.